Table 2.
Measure | Population | MDES | Time |
---|---|---|---|
ADAS-Cog11 | CN | ||
EMCI | |||
LMCI | 41% | 3 years | |
AD | 35% | 2 years | |
ADAS-Cog13 | CN | 89% | 6 years |
EMCI | |||
LMCI | 42% | 3 years | |
AD | 34% | 2 years | |
MMSE | CN | ||
EMCI | 99% | 4 years | |
LMCI | 34% | 3 years | |
AD | 35% | 2 years | |
MOCA | CN | ||
EMCI | |||
LMCI | 89% | 3 years | |
AD | 76% | 2 years | |
Hippocampus | CN | 35% | 6 years |
EMCI | 34% | 5 years | |
LMCI | 21% | 6 years | |
AD | 54% | 2 years | |
Whole brain | CN | ||
EMCI | |||
LMCI | |||
AD | |||
CDRSB | CN | 66% | 4 years |
EMCI | |||
LMCI | 28% | 2 years | |
AD | 30% | 2 years | |
FAQ | CN | 96% | 6 years |
EMCI | 81% | 4 years | |
LMCI | 27% | 3 years | |
AD | 28% | 2 years |
Empty rows indicate no effect can be detected over a 6 year trial